[31, 32] Fonnet et al found that in glioblastoma tumor samples occurrence of IDH1 R132 mutation reduced this capacity to produce NADPH by 38% and furthermore mutated IDH1 consumes rather than produces NADPH. Here, IDH1 is linked to neoplasm.